Clinical trial
6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With…
NCT00352144 · Sumitomo Pharma America, Inc., Industry · Completed
Key facts
| NCT number | NCT00352144 |
|---|---|
| Title | 6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia |
| Official title | A Six-Month, Chronic Efficacy and Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia: A Randomized Double-Blind, Placebo-Controlled Study |
| Lead sponsor | Sumitomo Pharma America, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Primary Insomnia |
| Intervention type | Drug |
| Interventions | Eszopiclone, Placebo |
| Enrollment | 830 |
| Start date | Oct 1, 2003 |
| Primary completion | Oct 1, 2004 |
| Completion | Oct 1, 2004 |
| First posted | Jul 14, 2006 |
| Last update posted | Feb 22, 2012 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: